An expert in the management of hypertrophic cardiomyopathy discusses the burden of disease, existing treatment options, unmet needs, and explores data from an emerging class of agents, myosin inhibitors.
EP. 1: HCM Overview and Presenting Symptoms
EP. 2: The Diagnosis of Hypertrophic Cardiomyopathy
EP. 3: Patient Burden: Healthcare Resources and Complications
EP. 4: Future of HCM: Allosteric Inhibitors of Cardiac Myosin
EP. 5: Promising Myosin Inhibitor Findings Presented at AHA
2 Clarke Drive Cranbury, NJ 08512